PA
AGIO icon

Parallel Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Parallel Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$742 Hold
20
– – ﹤0.01% 3737
2026
Q1 		$677 Buy
20
+8
+67% +$227 ﹤0.01% 3613
2025
Q4 		$327 Hold
12
– – ﹤0.01% 3466
2025
Q3 		$482 Hold
12
– – ﹤0.01% 3334
2025
Q2 		$399 Sell
12
-492
-98% -$14.9K ﹤0.01% 3335
2025
Q1 		$14.8K Buy
504
+12
+2% +$398 ﹤0.01% 2281
2024
Q4 		$16.2K Sell
492
-20
-4% -$940 ﹤0.01% 2236
2024
Q3 		$22.7K Buy
512
+20
+4% +$908 ﹤0.01% 2020
2024
Q2 		$21.2K Buy
+492
New +$17.8K ﹤0.01% 1948
2023
Q4 		– Sell
-23
Closed -$569 – 3318
2023
Q3 		$569 Hold
23
– – ﹤0.01% 3082
2023
Q2 		$651 Buy
+23
New +$572 ﹤0.01% 3044
2022
Q4 		– Sell
-4
Closed – – 3347
2022
Q3 		$0 Buy
+4
New +$107 ﹤0.01% 3112
2022
Q1 		– Sell
-9
Closed – – 2931
2021
Q4 		$0 Sell
9
-44
-83% -$1.77K ﹤0.01% 3051
2021
Q3 		$2K Sell
53
-18
-25% -$870 ﹤0.01% 2637
2021
Q2 		$4K Sell
71
-69
-49% -$3.86K ﹤0.01% 2336
2021
Q1 		$7K Buy
140
+38
+37% +$1.88K ﹤0.01% 2045
2020
Q4 		$4K Sell
102
-666
-87% -$26.3K ﹤0.01% 2066
2020
Q3 		$27K Sell
768
-794
-51% -$34.8K ﹤0.01% 1311
2020
Q2 		$83K Buy
1,562
+1,465
+1,510% +$67.8K 0.01% 831
2020
Q1 		$3K Sell
97
-40
-29% -$1.85K ﹤0.01% 2007
2019
Q4 		$7K Buy
137
+106
+342% +$4.01K ﹤0.01% 1839
2019
Q3 		$1K Buy
+31
New +$1.28K ﹤0.01% 2243
2018
Q3 		– Sell
-29
Closed -$2K – 2217
2018
Q2 		$2K Hold
29
– – ﹤0.01% 1808
2018
Q1 		$2K Buy
+29
New +$2.24K ﹤0.01% 1802

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Parallel Advisors's AGIO Position: Q2 2026 in Review

Parallel Advisors held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 20 shares worth $742. The position accounts for ﹤0.01% of the portfolio, ranked #3737.

Parallel Advisors first reported a position in AGIO in Q1 2018 and has held it in 24 quarters since. The position peaked at $83K in Q2 2020. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Parallel Advisors held 20 shares of Agios Pharmaceuticals worth $742 as of Q2 2026.
  • Parallel Advisors left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3737 holding.
  • Parallel Advisors first reported a position in Agios Pharmaceuticals in Q1 2018 and has held it in 24 quarters since.
  • Parallel Advisors's Agios Pharmaceuticals position peaked at $83K in Q2 2020.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.